Sorafenib and SIAIS361034, a novel PROTAC degrader of BCL-xL, display synergistic antitumor effects on hepatocellular carcinoma with minimal hepatotoxicity
已完结10由 honey 发布于 2026/4/1 23:55:03
DOI:10.1016/j.bcp.2024.116542
作者:Xiaoyi Zhang , Yachuan Tao , Zhongli Xu , Biao Jiang , Xiaobao Yang , Taomin Huang , Wenfu Tan
文献类型:期刊论文
补充材料:只需要正文